Nuvalent to Participate in the Piper Sandler 36th Annual Healthcare Conference
Nuvalent (NUVL), a clinical-stage biopharmaceutical company developing targeted cancer therapies, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's CEO James Porter and CFO Alexandra Balcom will engage in a fireside chat on December 3, 2024, at 3:30 p.m. ET in NYC. The presentation will be accessible via live webcast on Nuvalent's website investor section and will remain available for 30 days afterward.
Nuvalent (NUVL), un'azienda biofarmaceutica in fase clinica che sviluppa terapie mirate per il cancro, ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler. Il CEO dell'azienda, James Porter, e il CFO, Alexandra Balcom, parteciperanno a un incontro informale il 3 dicembre 2024, alle 15:30 ET a New York. La presentazione sarà accessibile tramite webcast live nella sezione investitori del sito web di Nuvalent e rimarrà disponibile per 30 giorni dopo.
Nuvalent (NUVL), una empresa biofarmacéutica en etapa clínica que desarrolla terapias dirigidas contra el cáncer, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. El CEO de la empresa, James Porter, y la CFO, Alexandra Balcom, participarán en una charla informal el 3 de diciembre de 2024, a las 3:30 p.m. ET en Nueva York. La presentación estará disponible a través de un webcast en vivo en la sección de inversores del sitio web de Nuvalent y permanecerá accesible durante 30 días después.
Nuvalent (NUVL), 임상 단계의 항암 치료제를 개발하는 생명공학 회사가 Piper Sandler 제36회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 CEO인 James Porter와 CFO인 Alexandra Balcom이 2024년 12월 3일 뉴욕시간 오후 3시 30분에 파이어사이드 차트에 참여할 예정입니다. 발표는 Nuvalent 웹사이트의 투자자 섹션을 통해 실시간 웹캐스트로 시청할 수 있으며, 이후 30일 동안 계속 이용 가능합니다.
Nuvalent (NUVL), une entreprise biopharmaceutique en phase clinique développant des thérapies ciblées contre le cancer, a annoncé sa participation à la 36ème Conférence Annuelle sur la Santé de Piper Sandler. Le PDG de l'entreprise, James Porter, et la CFO, Alexandra Balcom, participeront à une discussion informelle le 3 décembre 2024 à 15h30 ET à New York. La présentation sera accessible par le biais d'un webcast en direct dans la section investisseurs du site Web de Nuvalent et restera disponible pendant 30 jours par la suite.
Nuvalent (NUVL), ein biopharmazeutisches Unternehmen in klinischer Phase, das gezielte Krebsbehandlungen entwickelt, hat seine Teilnahme an der 36. jährlichen Healthcare-Konferenz von Piper Sandler bekannt gegeben. Der CEO des Unternehmens, James Porter, und die CFO, Alexandra Balcom, werden am 3. Dezember 2024 um 15:30 Uhr ET in New York an einem informellen Gespräch teilnehmen. Die Präsentation wird über einen Live-Webcast im Investorenbereich der Nuvalent-Website zugänglich sein und 30 Tage lang verfügbar bleiben.
- None.
- None.
A live webcast will be available in the Investors section of the company's website at www.nuvalent.com, and archived for 30 days following the presentation.
About Nuvalent
Nuvalent, Inc. (Nasdaq: NUVL) is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.
View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvalent-to-participate-in-the-piper-sandler-36th-annual-healthcare-conference-302316455.html
SOURCE Nuvalent, Inc.
FAQ
When is Nuvalent (NUVL) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch Nuvalent's (NUVL) presentation at the Piper Sandler Conference?
Who will represent Nuvalent (NUVL) at the Piper Sandler Healthcare Conference 2024?
What type of event will Nuvalent (NUVL) participate in at the Piper Sandler Conference?
